TrialA Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Trial details
- Registry ID
- NCT05357989
- Phase
- Phase 3
ANVS
Annovis Bio Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
4Trials in this database
2Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDNCT05357989 | ANVS | Phase 3 | Completed | 2023-12-04Actual |
| A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADNCT05686044 | ANVS | Phase 2, Phase 3 | Completed | 2024-02-13Actual |
| A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADNCT06709014 | ANVS | Phase 3 | Active not recruiting | 2027-12Estimated |
| A Study of Buntanetap in Participants With PDNCT07284784 | ANVS | Phase 2, Phase 3 | Recruiting | 2029-09Estimated |
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Trial details
- Registry ID
- NCT05686044
- Phase
- Phase 2, Phase 3
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Trial details
- Registry ID
- NCT06709014
- Phase
- Phase 3
A Study of Buntanetap in Participants With PD
Trial details
- Registry ID
- NCT07284784
- Phase
- Phase 2, Phase 3
Latest recorded trial changes
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
NCT06709014 · Annovis Bio Inc.
Recruitment status
Recorded edit− Previous value
Recruiting
+ Updated value
Active not recruiting
A Study of Buntanetap in Participants With PD
NCT07284784 · Annovis Bio Inc.
Recruitment status
Recorded edit− Previous value
Not yet recruiting
+ Updated value
Recruiting